Bank of New York Mellon’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $3.61M | Buy |
|
|||||
|
2022
Q2 | $1.71M | Buy |
|
|||||
|
2022
Q1 | $2.02M | Buy |
|
|||||
|
2021
Q4 | $1.4M | Sell |
|
|||||
|
2021
Q3 | $2.28M | Buy |
|
|||||
|
2021
Q2 | $3.03M | Sell |
|
|||||
|
2021
Q1 | $3.82M | Sell |
|
|||||
|
2020
Q4 | $2.93M | Sell |
|
|||||
|
2020
Q3 | $15M | Sell |
|
|||||
|
2020
Q2 | $19M | Sell |
|
|||||
|
2020
Q1 | $18.2M | Sell |
|
|||||
|
2019
Q4 | $33.5M | Buy |
|
|||||
|
2019
Q3 | $25.8M | Sell |
|
|||||
|
2019
Q2 | $46.2M | Sell |
|
|||||
|
2019
Q1 | $82.3M | Buy |
|
|||||
|
2018
Q4 | $52.9M | Buy |
|
|||||
|
2018
Q3 | $38.8M | Buy |
|
|||||
|
2018
Q2 | $42.6M | Buy |
|
|||||
|
2018
Q1 | $32.4M | Sell |
|
|||||
|
2017
Q4 | $36.6M | Buy |
|
|||||
|
2017
Q3 | $26.7M | Buy |
|
|||||
|
2017
Q2 | $23M | Buy |
|
|||||
|
2017
Q1 | $12M | Buy |
|
|||||
|
2016
Q4 | $7.45M | Buy |
|
|||||
|
2016
Q3 | $6.02M | Buy |
|
|||||
|
2016
Q2 | $2.33M | Buy |
|
|||||
|
2016
Q1 | $1.59M | Buy |
|
|||||
|
2015
Q4 | $3.1M | Sell |
|
|||||
|
2015
Q3 | $2.29M | Buy |
|
|||||
|
2015
Q2 | $1.76M | Buy |
|
|||||
|
2015
Q1 | $2.81M | Sell |
|
|||||
|
2014
Q4 | $2.67M | Buy |
|
|||||
|
2014
Q3 | $1.65M | Buy |
|
|||||
|
2014
Q2 | $956K | Buy |
|
|||||
|
2014
Q1 | $697K | Buy |
|
|||||
|
2013
Q4 | $425K | Buy |
|